Cancer immunotherapy in routine cost‐effective cancer care?

Abstract Therapy‐triggered autoimmunity and inflammation in many cancer patients, as well as treatment costs, hamper the success of cancer immunotherapy. The study by Pfeiffer et al in this issue of EMBO Molecular Medicine constitutes a clear step towards a more simple, scalable and affordable appro...

Full description

Saved in:
Bibliographic Details
Main Author: Sir Marc Feldmann
Format: Article
Language:English
Published: Springer Nature 2018-10-01
Series:EMBO Molecular Medicine
Online Access:https://doi.org/10.15252/emmm.201809660
Tags: Add Tag
No Tags, Be the first to tag this record!